Loading...

Balance Sheet Data

Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. (APVO)

Healthcare

Year
A/P
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Total Cash 3.594.6454.9281.1838.0860.6661.8062.9764.1565.36
Total Cash (%)
Account Receivables 13.826.460.312.145.224.224.304.384.464.55
Account Receivables (%)
Inventories 17.6320.320.461.031.795.575.675.785.896.00
Inventories (%)
Accounts Payable 11.4710.0810.527.3511.6712.2812.5112.7512.9813.23
Accounts Payable (%)
Capital Expenditure -0.99-1.53-2.51-1.40-0.98-2.15-2.19-2.23-2.27-2.31
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.